FDA approves first vaccine for respiratory syncytial virus
Drug Discovery World
JUNE 6, 2023
The US Food and Drug Administration (FDA) has approved Pfizer’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine Abrysvo in individuals 60 years and older. The post FDA approves first vaccine for respiratory syncytial virus appeared first on Drug Discovery World (DDW).
Let's personalize your content